Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis,unreasonably downplayed by the McDonald criteria 2010: Yes

Abstract

Get full access to this article

View all access options for this article.

References

Schumacher

Beeve

Kibler

. Problems of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965; 122: 552–568.

Poser

Paty

Scheinberg

. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227–231.

McDonald

Compston

Edan

. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–127.

Polman

Reingold

Edan

. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol 2005; 58: 840–846.

Polman

Reingold

Banwell

. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292–302.

Kabat

Moore

Landow

. An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins. J Clin Invest 1942; 21: 571–577.

Andersson

Alvarez-Cermeño

Bernardi

. Cerebrospinal fluid in the diagnosis of multiple sclerosis: A consensus report. J Neurol Neurosurg Psychiatry 1994; 57: 897–902.

Imrell

Landtblom

Hillert

. Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct. Neurology 2006; 67:1062–1064.

Mero

Gustavsen

Sæther

. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. PLoS ONE [in press]

10.

Lechner-Scott

Spencer

de Malmanche

. The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. Mult Scler 2012; 18: 974–982.

11.

Solomon

Klein

Bourdette

. ‘Undiagnosing’ multiple sclerosis: The challenge of misdiagnosis in MS. Neurology 2012; 78: 1986–1991.

12.

Sandberg–Wollheim

Optic neuritis: Studies on the cerebrospinal fluid in relation to clinical course in 61 patients. Acta Neurol Scand 1975; 52: 167–178.

13.

Moulin

Paty

Ebers

. The predictive value of cerebrospinal fluid electrophoresis in ‘possible’ multiple sclerosis. Brain 1983; 106: 809–816.

14.

Tintoré

Rovira

Brieva

. Isolated demyelinating syndromes: Comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS. Mult Scler 2001; 7: 359–363.

15.

Tintoré

Rovira

Río

. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 2008; 70: 1079–1083.

16.

Barkhof

Filippi

Miller

. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059–2069.

17.

Lebrun

Bensa

Debouverie

. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential. Arch Neurol 2009; 66: 841–846.

18.

Lebrun

Blanc

Brassat

. Cognitive function in radiologically isolated syndrome. Mult Scler 2010; 16: 919–925.

19.

Khademi

Kockum

Andersson

. Cerebrospinal fluid CXCL13 in multiple sclerosis: A suggestive prognostic marker for the disease course. Mult Scler 2011; 17: 335–343.

20.

Gunnarsson

Malmeström

Axelsson

. Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. Ann Neurol 2011; 69: 83–89.